TaiMed Biologics (Taiwan) Probability of Future Stock Price Finishing Over 91.04
| 4147 Stock | TWD 83.00 2.10 2.47% |
TaiMed |
TaiMed Biologics Target Price Odds to finish over 91.04
The tendency of TaiMed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over NT$ 91.04 or more in 90 days |
| 83.00 | 90 days | 91.04 | near 1 |
Based on a normal probability distribution, the odds of TaiMed Biologics to move over NT$ 91.04 or more in 90 days from now is near 1 (This TaiMed Biologics probability density function shows the probability of TaiMed Stock to fall within a particular range of prices over 90 days) . Probability of TaiMed Biologics price to stay between its current price of NT$ 83.00 and NT$ 91.04 at the end of the 90-day period is about 25.34 .
Assuming the 90 days trading horizon TaiMed Biologics has a beta of -0.0851. This suggests as returns on the benchmark increase, returns on holding TaiMed Biologics are expected to decrease at a much lower rate. During a bear market, however, TaiMed Biologics is likely to outperform the market. Additionally TaiMed Biologics has an alpha of 0.0623, implying that it can generate a 0.0623 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). TaiMed Biologics Price Density |
| Price |
Predictive Modules for TaiMed Biologics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TaiMed Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.TaiMed Biologics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. TaiMed Biologics is not an exception. The market had few large corrections towards the TaiMed Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold TaiMed Biologics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of TaiMed Biologics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | -0.09 | |
σ | Overall volatility | 3.41 | |
Ir | Information ratio | -0.02 |
TaiMed Biologics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TaiMed Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TaiMed Biologics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the revenue of 413.44 M. Net Loss for the year was (470.93 M) with profit before overhead, payroll, taxes, and interest of 177.82 M. | |
| TaiMed Biologics has accumulated about 1.02 B in cash with (211.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.03. | |
| Roughly 17.0% of the company shares are owned by insiders or employees |
TaiMed Biologics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TaiMed Stock often depends not only on the future outlook of the current and potential TaiMed Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TaiMed Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 252.3 M |
TaiMed Biologics Technical Analysis
TaiMed Biologics' future price can be derived by breaking down and analyzing its technical indicators over time. TaiMed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TaiMed Biologics. In general, you should focus on analyzing TaiMed Stock price patterns and their correlations with different microeconomic environments and drivers.
TaiMed Biologics Predictive Forecast Models
TaiMed Biologics' time-series forecasting models is one of many TaiMed Biologics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TaiMed Biologics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about TaiMed Biologics
Checking the ongoing alerts about TaiMed Biologics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TaiMed Biologics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company reported the revenue of 413.44 M. Net Loss for the year was (470.93 M) with profit before overhead, payroll, taxes, and interest of 177.82 M. | |
| TaiMed Biologics has accumulated about 1.02 B in cash with (211.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.03. | |
| Roughly 17.0% of the company shares are owned by insiders or employees |
Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.